RE: Bioniche Q2 Results Wow. With so many negatives, where does one begin?
"The Company incurred financing expenses of $3.2 million during the first six months of Fiscal 2013 as a result of its US$20 million debt financing with Capital Royalty Partners. This compares to financing expenses of $0.2 million in the same period of Fiscal 2012."
I'll listen to the next conference call and then flip a coin to decide whether I'm in or out. But I'm thinking it is time to move on.